Biotechnology The skeptic: What precision medicine revolution? The benefits of genomic drugs are exaggerated, hurting patients and the practice of medicine, says one high-profile oncologist. by Stephen S. Hall 2018-10-23T05:00:00-04:00
Biotechnology Biohackers Disregard FDA Warning on DIY Gene Therapy The agency seeks a crackdown on companies offering kits to produce gene therapies for self-administration. by Emily Mullin 2017-12-01T10:00:00-05:00
Rewriting Life FDA Opens Genetic Floodgates with 23andMe Decision Gene-testing companies will be able to directly tell consumers their risk for certain diseases. by Emily Mullin 2017-04-06T17:56:00-04:00
Rewriting Life What If the Free Market Decided Whether or Not Drugs Work? President Trump’s pick to lead the country’s drug regulatory agency could usher in major reforms. by Emily Mullin 2017-02-03T16:08:00-05:00
Connectivity FDA E-mails Reveal Apple’s Long Game for Health Tech Close communications with the agency suggest that Apple is heavily invested in developing medical equipment—but is in no hurry about it. by Jamie Condliffe 2016-11-29T11:30:00-05:00
Rewriting Life Device Lets Cancer Patients Assist in Their Own Breast Reconstruction, at Home A needleless, remote-controlled device for tissue expansion is awaiting FDA approval. by Emily Mullin 2016-11-03T00:00:00-04:00
Rewriting Life The Unintended Consequence of Congress’s Ban on Designer Babies The testing of new therapies to prevent a debilitating mitochondrial genetic disease in babies has hit a dead end. by Mike Orcutt 2016-08-26T00:00:00-04:00
Rewriting Life The White House Is Pushing Precision Medicine, but It Won’t Happen for Years For starters, it’s too expensive and the science isn’t advanced enough. by Mike Orcutt 2016-07-18T00:00:00-04:00
Rewriting Life A Shot in the Arm for Obama’s Precision Medicine Initiative The White House says a huge new database and better genetic testing will help realize the enormous promise of personalized medicine. by Mike Orcutt 2016-07-07T18:10:00-04:00
Rewriting Life Clinics Offering Unproven Stem Cell Therapies Are Proliferating Across the U.S. Patients don’t need “stem cell tourism” anymore—ineffective and potentially dangerous interventions abound at home. by Ryan Cross 2016-06-30T14:38:00-04:00
